Pharmaceuticals

Dry Eye Medication Market to Grow at a CAGR of 10.5% from 2025 to 2029

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Are The Current (2025) And Forecast (2029) Sizes Of The Dry Eye Medication Market?

The dry eye medication market size has seen rapid growth in recent years. It is anticipated to increase from $10.96 billion in 2024 to $12.13 billion in 2025, progressing at a compound annual growth rate (CAGR) of 10.7%. The expansion observed in the historic period is largely attributable to an aging population, an increasing number of contact lens users, a rise in disposable income, more available treatment options, a surge in allergies, higher consumption of unhealthy or improper diets, and the prevalence of diabetes mellitus.

The dry eye medication market is projected to experience substantial expansion over the upcoming years, with an anticipated valuation of $18.08 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 10.5%. Several factors are expected to drive this growth during the forecast period, including an increase in laser surgeries, prolonged screen time, demanding lifestyles, the growing incidence of diabetes, a higher prevalence of dry eye disease, a promising drug pipeline for the condition, and adverse effects associated with other medications. Key trends anticipated during this period involve the creation of preservative-free eye drops, significant investment in the research and development of novel and advanced pharmaceutical products, the formulation of innovative drugs to maintain market presence, the advancement of non-steroidal anti-inflammatory ophthalmic drugs for dry-eye syndrome, an emphasis on integrating contemporary techniques, and the evolution of combination therapies for managing dry eye conditions.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3807&type=smp

What Are The Top Growth Drivers Impacting The Dry Eye Medication Market Outlook?

The growing incidence of dry eye disease leads to a greater need for its therapeutic solutions. Several elements contribute to the heightened likelihood of dry eye, including advancing age, insufficient vitamin A, contact lens usage, ophthalmic procedures, exposure to arid wind or smoke, and prolonged screen time. For instance, the American Academy of Ophthalmology reported that in the USA, approximately 3.2 million women and 1.68 million men aged over 50 suffered from dry eye syndrome. Likewise, research published in the Indian Journal of Ophthalmology revealed a 32% prevalence of dry eye disease in the Northern part of India. This escalating prevalence of the condition is expected to fuel the demand for its treatment, thereby boosting the expansion of the dry eye medication market.

How Is The Dry Eye Medication Market Classified Into Different Segments?

The dry eye medication market covered in this report is segmented –

1) By Type Of Product: Aqueous, Evaporative, Aqueous and Evaporative

2) By Delivery System: Liquid, Gel, Ointment, Other Delivery System

3) By Prescription Type: OTC Drugs, Prescription Drugs

4) By End-User: Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Aqueous: Artificial Tears (lubricating eye drops), Prescription Eye Drops, Ophthalmic Solutions

2) By Evaporative: Punctal Plugs (to reduce tear drainage), Lipid-Based Eye Drops, Eye Ointments (with lipid components)

3) By Aqueous and Evaporative: Combination Eye Drops (formulated to address both aqueous And evaporative dry eye), Multi-Action Eye Care Products

What Long-Term Trends Will Shape The Future Growth Of The Dry Eye Medication Industry?

Leading companies in the dry eye medication market are actively developing innovative products, such as Cyclosporine ophthalmic solutions, aimed at stimulating tear production, reducing ocular inflammation, and delivering long-term relief. These Cyclosporine ophthalmic solutions are prescription eye drops containing the immunosuppressant cyclosporine, primarily used to treat dry eye disease by enhancing tear production and decreasing inflammation in the eyes. For example, in June 2023, Novaliq GmbH, a Germany-based biopharmaceutical company, announced the U.S. Food and Drug Administration (FDA) approval of VEVYE (cyclosporine ophthalmic solution) 0.1% for managing the signs and symptoms of dry eye disease. VEVYE (development name CyclASol) stands as the first and only cyclosporine solution specifically approved for treating dry eye disease’s signs and symptoms, demonstrating efficacy within just four weeks of treatment. Formulated with a novel, water-free excipient, VEVYE addresses unmet patient needs by offering a fast-acting and well-tolerated therapy for dry eyes. Unlike traditional solutions, it is free from water, anti-microbial preservatives, oils, and surfactants, thereby eliminating concerns related to pH and osmolarity.

Who Are The Top Performing Companies In The Dry Eye Medication Market In Recent Years?

Major companies operating in the dry eye medication market include Allergan plc, Alcon Inc., Bausch Health Companies Inc., Novartis AG, Otsuka Holdings Co. Ltd., Santen Pharmaceutical Co., Ltd., Sentiss Pharma Pvt. Ltd., OASIS Medical, Inc., VISUfarma B.V., Sun Pharmaceutical Industries Limited, Bayer AG, Pfizer, Johnson & Johnson, Daiichi Sankyo, Zhaoke Ophthalmology Pharmaceutical, Vision gain, Implandata ophthalmic products GmbH, The Geuder Group, Novamedika, Aflofarm Farmacja Polska, VUAB Pharma Inc., Herzig Eye Institute, Thomas Eye Group, Alimera Sciences, Eyegate, Neurotech, Opthotech, Eyepoint pharmaceuticals, ReGenTree, LLC, Regenerx Biopharmaceuticals Inc, shire, Gama Vision, Biolab Pharma, Mitotech, Novaliq GmbH, Horus Pharma, Prestige Consumer Healthcare Inc., Azura Ophthamics Ltd, Similasan, Hoya Corporation, Adcock Ingram.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/dry-eye-medication-global-market-report

Which Region Shows The Highest Potential For Future Expansion In The Dry Eye Medication Market?

North America was the largest region in the market in 2024. Middle East is expected to be the fastest-growing region in the global dry eye medication market share during the forecast period. The regions covered in the dry eye medication market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Dry Eye Medication Market Report:

https://www.thebusinessresearchcompany.com/customise?id=3807&type=smp

Browse Through More Reports Similar to the Global Dry Eye Medication Market 2025, By The Business Research Company

Healthcare Personal Protective Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/healthcare-personal-protective-equipment-global-market-report

Ophthalmology Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/ophthalmology-drugs-global-market-report

Intraocular Lens Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/intraocular-lens-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795